Recently, the systemic inflammatory response, as evidenced by elevated circulating concentrations of C-reactive protein, has been shown to be independently associated with poorer survival in patients with advanced cancer (O’Gorman et al, 2000; Forrest et al, 2003; Maltoni et al, 2005). The gene discussed is CRP; the disease is cancer.